Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-09 Sale |
2024-01-11 5:06 pm |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
4,000 | $15.19 | $60,751 | 11,114 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-15 Option Award |
2024-04-24 10:20 am |
N/A N/A |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO |
15,000 | $0 | 553,144 (Direct) |
View |
| 2024-02-15 Option Award |
2024-04-24 10:18 am |
N/A N/A |
OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer |
4,000 | $0 | 7,848 (Direct) |
View |
| 2024-02-15 Option Award |
2024-04-24 10:17 am |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
4,267 | $0 | 18,498 (Direct) |
View |
| 2024-02-15 Option Award |
2024-04-24 10:16 am |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
7,083 | $0 | 14,765 (Direct) |
View |
| 2024-03-15 Option Award |
2024-04-24 10:04 am |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
7,750 | $0 | 13,706 (Direct) |
View |
| 2023-10-11 Exercise(A) |
2024-04-22 08:37 am |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
8,221 | $0 | 28,034 (Direct) |
View |
| 2022-10-11 Tax Withholding(A) |
2024-04-22 08:31 am |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
3,539 | $15.17 | 7,682 (Direct) |
View |
| 2024-04-15 Option Award |
2024-04-17 5:22 pm |
N/A N/A |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO |
60,000 | $0 | 538,144 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-06 4:20 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
1,927 | $0 | 7,884 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-06 4:20 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
668 | $15.95 | 7,884 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-06 4:19 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
771 | $0 | 15,002 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-06 4:19 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
268 | $15.95 | 15,002 (Direct) |
View |
| 2023-12-19 Option Award |
2024-02-21 6:25 pm |
N/A 2026-12-19 |
OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer |
11,784 | $0 | 11,784 (Direct) |
View |
| 2023-12-19 Option Award |
2024-02-21 6:24 pm |
N/A 2026-12-19 |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
31,422 | $0 | 31,422 (Direct) |
View |
| 2023-12-19 Option Award |
2024-02-21 6:23 pm |
2024-12-19 2026-12-19 |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
23,566 | $0 | 23,566 (Direct) |
View |
| 2023-12-19 Option Award |
2024-02-21 6:22 pm |
N/A 2026-12-19 |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
39,278 | $0 | 39,278 (Direct) |
View |
| 2024-02-11 Exercise |
2024-02-13 6:16 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
4,000 | $0 | 29,728 (Direct) |
View |
| 2024-02-11 Tax Withholding |
2024-02-13 6:16 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
1,386 | $15.39 | 29,728 (Direct) |
View |
| 2024-02-02 Option Award |
2024-02-06 7:53 pm |
N/A N/A |
OptimizeRx Corp | OPRX | KLEMA CATHY Director |
5,109 | $0 | 5,109 (Direct) |
View |
| 2024-01-09 Exercise |
2024-01-18 5:56 pm |
N/A N/A |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO |
9,628 | $0 | 478,144 (Direct) |
View |
| 2024-01-09 Tax Withholding |
2024-01-18 5:56 pm |
N/A N/A |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO |
2,884 | $13.25 | 478,144 (Direct) |
View |
| 2023-11-08 Exercise |
2023-11-13 2:32 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
1,785 | $0 | 16,899 (Direct) |
View |
| 2023-11-08 Tax Withholding |
2023-11-13 2:32 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
524 | $9.21 | 16,899 (Direct) |
View |
| 2023-11-01 Option Award |
2023-11-03 10:49 am |
N/A 2028-11-01 |
OptimizeRx Corp | OPRX | Greco Theresa Chief Commercial Officer |
54,277 | $0 | 72,796 (Direct) |
View |
Ownership |
2023-10-30 4:06 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Greco Theresa Chief Commercial Officer |
0 | $0 | 21,089 (Direct) |
View |
| 2022-10-11 Exercise |
2023-10-12 2:18 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
22,597 | $0 | 54,202 (Direct) |
View |
| 2023-10-11 Tax Withholding |
2023-10-12 2:18 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
2,066 | $7.15 | 54,202 (Direct) |
View |
| 2023-10-03 Exercise |
2023-10-06 2:47 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
6,649 | $0 | 27,151 (Direct) |
View |
| 2023-10-03 Tax Withholding |
2023-10-06 2:47 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
1,952 | $7.06 | 27,151 (Direct) |
View |
| 2023-10-03 Exercise |
2023-10-06 2:47 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
6,649 | $0 | 17,995 (Direct) |
View |
| 2023-10-03 Tax Withholding |
2023-10-06 2:47 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
1,952 | $7.06 | 17,995 (Direct) |
View |
| 2023-10-03 Exercise |
2023-10-06 2:47 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
16,662 | $0 | 50,432 (Direct) |
View |
| 2023-10-03 Tax Withholding |
2023-10-06 2:47 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
4,117 | $7.06 | 50,432 (Direct) |
View |
| 2023-10-03 Exercise |
2023-10-06 2:47 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer |
3,324 | $0 | 10,497 (Direct) |
View |
| 2023-10-03 Tax Withholding |
2023-10-06 2:47 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer |
976 | $7.06 | 10,497 (Direct) |
View |
| 2023-06-07 Exercise |
2023-08-18 10:03 am |
N/A N/A |
OptimizeRx Corp | OPRX | HALAS GUS D Director |
4,637 | $0 | 80,926 (Direct) |
View |
| 2023-06-07 Option Award |
2023-08-18 10:03 am |
N/A N/A |
OptimizeRx Corp | OPRX | HALAS GUS D Director |
10,061 | $0 | 80,926 (Direct) |
View |
| 2023-06-07 Exercise |
2023-08-18 09:33 am |
N/A N/A |
OptimizeRx Corp | OPRX | Spangler Patrick D Director |
4,637 | $0 | 32,181 (Direct) |
View |
| 2023-06-07 Option Award |
2023-08-18 09:33 am |
N/A N/A |
OptimizeRx Corp | OPRX | Spangler Patrick D Director |
10,061 | $0 | 32,181 (Direct) |
View |
| 2023-06-07 Exercise |
2023-08-18 09:31 am |
N/A N/A |
OptimizeRx Corp | OPRX | Lang James Paul Director |
4,637 | $0 | 54,758 (Direct) |
View |
| 2023-06-07 Option Award |
2023-08-18 09:31 am |
N/A N/A |
OptimizeRx Corp | OPRX | Lang James Paul Director |
10,061 | $0 | 54,758 (Direct) |
View |
| 2023-06-07 Exercise |
2023-08-18 09:29 am |
N/A N/A |
OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director |
4,637 | $0 | 49,488 (Direct) |
View |
| 2023-06-07 Option Award |
2023-08-18 09:29 am |
N/A N/A |
OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director |
10,061 | $0 | 49,488 (Direct) |
View |
| 2023-06-07 Exercise |
2023-08-18 09:28 am |
N/A N/A |
OptimizeRx Corp | OPRX | WASSON GREGORY D Director |
4,637 | $0 | 34,029 (Direct) |
View |
| 2023-06-07 Option Award |
2023-08-18 09:28 am |
N/A N/A |
OptimizeRx Corp | OPRX | WASSON GREGORY D Director |
10,061 | $0 | 34,029 (Direct) |
View |
| 2023-04-18 Option Award |
2023-04-20 3:15 pm |
N/A N/A |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO |
248,383 | $0 | 248,383 (Direct) |
View |
| 2023-03-30 Exercise |
2023-04-03 12:22 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Lang James Paul Director |
657 | $0 | 40,717 (Direct) |
View |
| 2023-03-30 Exercise |
2023-04-03 12:22 pm |
N/A N/A |
OptimizeRx Corp | OPRX | HALAS GUS D Director |
657 | $0 | 66,885 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-03 12:22 pm |
N/A N/A |
OptimizeRx Corp | OPRX | WASSON GREGORY D Director |
657 | $0 | 19,988 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-03 12:19 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Spangler Patrick D Director |
657 | $0 | 18,140 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-03 12:18 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director |
657 | $0 | 35,447 (Direct) |
View |
| 2022-10-11 Exercise |
2023-03-30 12:19 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
8,221 | $0 | 21,125 (Direct) |
View |
| 2022-10-11 Tax Withholding |
2023-03-30 12:19 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
6,539 | $15.17 | 21,125 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-03 3:41 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
771 | $0 | 10,698 (Direct) |
View |
| 2023-03-01 Tax Withholding |
2023-03-03 3:41 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
268 | $18.11 | 10,698 (Direct) |
View |